Simplify Asset Management Inc. Buys 125,946 Shares of Alignment Healthcare, Inc. $ALHC

Simplify Asset Management Inc. lifted its stake in Alignment Healthcare, Inc. (NASDAQ:ALHC) by 92.0% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 262,880 shares of the company’s stock after purchasing an additional 125,946 shares during the period. Simplify Asset Management Inc.’s holdings in Alignment Healthcare were worth $5,192,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. William Blair Investment Management LLC boosted its position in shares of Alignment Healthcare by 8.7% in the 4th quarter. William Blair Investment Management LLC now owns 2,305,255 shares of the company’s stock worth $45,529,000 after purchasing an additional 185,303 shares during the last quarter. Investment House LLC bought a new position in shares of Alignment Healthcare in the 4th quarter worth $1,665,000. PNC Financial Services Group Inc. boosted its position in shares of Alignment Healthcare by 203.1% in the 4th quarter. PNC Financial Services Group Inc. now owns 10,483 shares of the company’s stock worth $207,000 after purchasing an additional 7,024 shares during the last quarter. GSA Capital Partners LLP boosted its position in shares of Alignment Healthcare by 162.7% in the 4th quarter. GSA Capital Partners LLP now owns 86,227 shares of the company’s stock worth $1,703,000 after purchasing an additional 53,402 shares during the last quarter. Finally, Handelsbanken Fonder AB boosted its position in shares of Alignment Healthcare by 26.1% in the 4th quarter. Handelsbanken Fonder AB now owns 30,000 shares of the company’s stock worth $592,000 after purchasing an additional 6,200 shares during the last quarter. 86.19% of the stock is currently owned by institutional investors.

Alignment Healthcare Stock Performance

NASDAQ ALHC opened at $16.35 on Monday. The firm has a market cap of $3.38 billion, a P/E ratio of 181.67, a P/E/G ratio of 2.29 and a beta of 1.26. The company has a debt-to-equity ratio of 1.56, a current ratio of 1.58 and a quick ratio of 1.58. The stock’s 50-day moving average is $18.84 and its 200-day moving average is $19.43. Alignment Healthcare, Inc. has a one year low of $11.63 and a one year high of $23.87.

Alignment Healthcare (NASDAQ:ALHC) last released its quarterly earnings results on Thursday, April 30th. The company reported $0.05 EPS for the quarter, topping analysts’ consensus estimates of $0.01 by $0.04. The company had revenue of $1.24 billion for the quarter, compared to analyst estimates of $1.22 billion. Alignment Healthcare had a return on equity of 11.50% and a net margin of 0.47%.Alignment Healthcare’s revenue was up 33.3% compared to the same quarter last year. During the same quarter last year, the firm posted ($0.05) earnings per share. Sell-side analysts anticipate that Alignment Healthcare, Inc. will post 0.19 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on ALHC shares. JPMorgan Chase & Co. raised their price target on Alignment Healthcare from $23.00 to $26.00 and gave the stock an “overweight” rating in a research report on Thursday, February 5th. Wolfe Research started coverage on Alignment Healthcare in a research report on Friday, April 17th. They issued an “outperform” rating and a $24.00 price target on the stock. Weiss Ratings upgraded Alignment Healthcare from a “sell (d-)” rating to a “hold (c-)” rating in a research report on Thursday, May 7th. Raymond James Financial set a $22.00 target price on Alignment Healthcare in a research note on Thursday, May 7th. Finally, Robert W. Baird set a $28.00 target price on Alignment Healthcare in a research note on Friday, January 30th. Two equities research analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $24.60.

Insiders Place Their Bets

In related news, President Dawn Christine Maroney sold 30,000 shares of the business’s stock in a transaction on Friday, May 15th. The shares were sold at an average price of $16.09, for a total value of $482,700.00. Following the sale, the president directly owned 998,813 shares of the company’s stock, valued at approximately $16,070,901.17. The trade was a 2.92% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Andreas P. Wagner sold 11,602 shares of the company’s stock in a transaction dated Thursday, March 19th. The stock was sold at an average price of $18.22, for a total value of $211,388.44. Following the transaction, the insider directly owned 148,628 shares of the company’s stock, valued at $2,708,002.16. This represents a 7.24% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 1,569,859 shares of company stock worth $29,433,158 in the last ninety days. 5.20% of the stock is owned by insiders.

About Alignment Healthcare

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.